Craneotomía en paciente con Enfermedad de Parkinson, apomorfina y neuroestimulador cerebral
Keywords:
Enfermedad de Parkinson, Manejo perioperatorio de la Enfermedad de Parkinson, Anestesia en la Enfermedad de Parkinson, Apomorfina, Neuroestimulación cerebral, Craneotomía, Parkinson, apomorphine, brain neurostimulatorAbstract
Parkinson's disease (PD) is the second most frequent neurodegenerative disease. Due to its high incidence and the increased survival of these patients, it is becoming more common undergoing surgical interventions. For the anesthesiologist it is important to know the management of this disease and its perioperative optimization. We present the case of a patient with severe PD undergoing craniotomy for resection of schwannoma of the 8th cranial nerve while being treated with antiparkinsonian drugs, apomorphine and brain neurostimulator.
References
- De Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006; 5(6): 525-35.
- Van Laar T, Borgemeester R. The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine. Parkinsonism an Releated Disorders. 2016; 33: S22-S27.
- Yeoh TY, Kalia SK. Anesthesia considerations for patients with an implanted deep brain stimulator undergoing surgery: a review and update. Can J Anesth. 2017; 64: 308-319.
- González-Latapi P, Cervantes-Arriaga, Rodríguez-Violante M. Consideraciones perioperatorias en pacientes con enfermedad de Parkinson: implicaciones farmacológicas. Gaceta Médica de México. 2013; 149: 334-43.
- Nicholson G, Pereira AC, Hall GM. Parkinson's disease and anaesthesia. Br J Anaesth. 2002; 89:904–16.
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Revista Electrónica AnestesiaR
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Envío y derechos de autor